Screen a child with obesity for red flags suggesting monogenic, syndromic, or secondary endocrine causes — distinguishing atypical from typical exogenous obesity. Trigger when a clinician asks whether obesity could be genetic or hormonal, suspects Prader-Willi syndrome, Cushing disease, hypothyroidism, ROHHAD, Bardet-Biedl syndrome, leptin deficiency, or craniopharyngioma, or when a child has early-onset severe obesity, short stature with obesity, hyperphagia, hypotonia, dysmorphic features, ...
Scanned 9/9/2026
Install to Claude Code
npx -y skills add dromlakhani/MD2SKILL --skill pediatric-obesity-etiology-screener --agent claude-codeInstalls into .claude/skills of the current project.
Are you the author of Pediatric Obesity Etiology Screener?
Add the live security badge to your README — it updates automatically with every re-scan.
[](https://www.skillsdirectory.com/skills/dromlakhani-pediatric-obesity-etiology-screener)More formats (shields.io, HTML) on the badges page.
---
name: pediatric-obesity-etiology-screener
description: Screen a child with obesity for red flags suggesting monogenic, syndromic, or secondary endocrine causes — distinguishing atypical from typical exogenous obesity. Trigger when a clinician asks whether obesity could be genetic or hormonal, suspects Prader-Willi syndrome, Cushing disease, hypothyroidism, ROHHAD, Bardet-Biedl syndrome, leptin deficiency, or craniopharyngioma, or when a child has early-onset severe obesity, short stature with obesity, hyperphagia, hypotonia, dysmorphic features, or developmental delay with weight gain.
---
# Pediatric Obesity: Atypical Etiology Screener
Distinguish typical exogenous obesity from monogenic, syndromic, or secondary endocrine causes using a structured red flag screen.
---
## Step 1 — Establish the Typical Baseline
**Typical exogenous obesity looks like this — if ALL present, atypical cause is less likely:**
| Feature | Typical Exogenous Obesity |
|---|---|
| Onset | Gradual, often after age 5 |
| Height | Normal to **tall** for age (advanced skeletal maturation) |
| Development | Normal milestones |
| Appetite | Increased but not insatiable |
| Dysmorphic features | Absent |
| Family history | Usually positive for obesity |
> ⚠️ If **any** feature deviates from the above, proceed through the red flag screen below.
---
## Step 2 — Red Flag Screen
Work through each domain. One or more flags = investigate further.
---
### 🔴 Domain 1: Age and Onset of Obesity
| Red Flag | Suspect |
|---|---|
| Obesity onset **before age 2–5 years**, especially severe | Monogenic obesity: leptin deficiency, leptin receptor deficiency, POMC deficiency, MC4R mutation |
| **Abrupt, rapid** weight gain at any age | Hypothalamic lesion (craniopharyngioma), ROHHAD/ROHHADNET syndrome, new-onset endocrine disorder |
---
### 🔴 Domain 2: Growth Pattern
| Red Flag | Suspect |
|---|---|
| **Short stature** in a child with obesity | Endocrine cause (Cushing disease, hypothyroidism, GH deficiency) or genetic syndrome |
| **Declining height velocity** despite obesity | Endocrine disorder — especially Cushing or hypothyroidism |
> 📏 **Key rule:** Exogenous obesity accelerates growth. A child with obesity who is short or growing slowly almost certainly has a non-exogenous cause. This is one of the most important red flags in paediatric practice.
---
### 🔴 Domain 3: Appetite
| Red Flag | Suspect |
|---|---|
| **Marked, uncontrollable hyperphagia** — insatiable hunger, food-seeking behaviour, food obsession | Monogenic obesity (leptin deficiency, POMC deficiency, MC4R), Prader-Willi syndrome, hypothalamic obesity |
---
### 🔴 Domain 4: Development and Neurology
| Red Flag | Suspect |
|---|---|
| **Developmental delay or intellectual disability** | Syndromic causes: Prader-Willi, Bardet-Biedl, Cohen syndrome |
| **Hypotonia in infancy** followed by hyperphagia and rapid weight gain in early childhood | Prader-Willi syndrome (classic presentation) |
| **Headaches, nausea, vision changes, nystagmus** | Craniopharyngioma or other hypothalamic-pituitary tumour |
| Autonomic dysregulation, hypoventilation | ROHHAD/ROHHADNET syndrome |
---
### 🔴 Domain 5: Physical and Genitourinary Findings
| Red Flag | Suspect |
|---|---|
| **Dysmorphic features** — unusual facies, small hands/feet, polydactyly | Bardet-Biedl syndrome (polydactyly), Prader-Willi syndrome, other chromosomal syndromes |
| **Delayed or absent puberty**, undescended testes, micropenis, small testes | Prader-Willi syndrome, Bardet-Biedl syndrome, leptin deficiency, endocrine cause |
| **Precocious puberty** | CNS lesion, ROHHAD syndrome |
| **Pale skin with red hair** (in White individuals) | POMC deficiency (classic triad: early-onset obesity + red hair + adrenal insufficiency) |
| **Retinal pigmentation, visual impairment, or deafness** | Bardet-Biedl syndrome, Alström syndrome |
| **Dry/coarse hair, constipation, cold intolerance, bradycardia** | Hypothyroidism |
| **Violaceous striae, interscapular fat pad (buffalo hump), moon facies, proximal myopathy, hypertension** | Cushing syndrome / Cushing disease |
| **Polydipsia, polyuria** | Diabetes insipidus (hypothalamic cause), or new-onset T1DM masking with insulin-driven weight gain |
---
## Step 3 — Triage by Flag Pattern
| Flags Present | Most Likely Cause | Urgency |
|---|---|---|
| Onset < 2 yrs + severe hyperphagia, no dysmorphia | Monogenic obesity (leptin, POMC, MC4R) | Elective referral to paediatric endocrinology/genetics |
| Neonatal hypotonia + later hyperphagia + developmental delay + hypogonadism + small hands/feet | **Prader-Willi syndrome** | Genetic testing (methylation studies) — confirm urgently |
| Polydactyly + retinal dystrophy + intellectual disability + hypogonadism | **Bardet-Biedl syndrome** | Genetics + ophthalmology referral |
| Short stature + obesity + violaceous striae + buffalo hump | **Cushing syndrome** | Endocrine workup (24h UFC, midnight salivary cortisol, low-dose DST) |
| Short stature + obesity + dry skin + constipation + bradycardia | **Hypothyroidism** | TSH + Free T4 — urgent |
| GH deficiency signs + short stature + obesity | **GH deficiency** | IGF-1, IGFBP-3, GH stimulation testing |
| Rapid-onset obesity + autonomic dysfunction + hypoventilation | **ROHHAD/ROHHADNET** | Urgent paediatric neurology/respirology |
| Headaches + visual changes + rapid weight gain | **Craniopharyngioma** | Urgent MRI brain/pituitary |
| Red hair + early-onset obesity + adrenal insufficiency signs | **POMC deficiency** | Urgent cortisol, ACTH, genetics |
| Visual impairment + sensorineural deafness + obesity | **Alström syndrome** | Genetics + ophthalmology |
---
## Step 4 — Initial Investigations to Order
Based on red flags identified, order as indicated:
**Endocrine screen (if short stature, striae, or growth deceleration):**
- TSH, Free T4
- 24-hour urinary free cortisol or midnight salivary cortisol
- Morning cortisol + ACTH
- IGF-1, IGFBP-3
**Genetic/syndromic workup:**
- Chromosomal microarray (for dysmorphic features or intellectual disability)
- Prader-Willi methylation studies (if clinical features present)
- Specific gene panel (leptin, leptin receptor, POMC, MC4R, BBS genes) via genetics referral
**Neuroimaging:**
- MRI brain and pituitary (if headaches, visual symptoms, rapid-onset hypothalamic obesity, or ROHHAD suspected)
**Ophthalmology:**
- Fundoscopy / ERG (if Bardet-Biedl or Alström suspected)
---
## Clinical Guardrails
- **Short stature + obesity = endocrine cause until proven otherwise.** Do not attribute growth failure to obesity alone.
- **POMC deficiency is rare but treatable** — setmelanotide (MC4R agonist) is approved; early identification matters.
- **Leptin deficiency** is also treatable with recombinant leptin — do not miss it in severe early-onset obesity.
- **Prader-Willi:** Genetic confirmation should precede growth hormone therapy (standard of care in PWS); confirm before starting.
- **Cushing in children is almost always ACTH-dependent (Cushing disease)** — screen carefully; obesity + hypertension + poor linear growth is the triad.
- **ROHHAD is life-threatening** — hypoventilation can cause sudden death; refer urgently if suspected.
- **Monogenic obesity does not exclude pharmacotherapy** — GLP-1RAs and setmelanotide may still be appropriate after diagnosis.
---
## Source
Clinical content synthesised from:
- CMAJ 2025 Clinical Practice Guideline: *Managing obesity in children.* Ball GDC et al. doi: [10.1503/cmaj.241456](https://doi.org/10.1503/cmaj.241456)
- Choquet H, Meyre D. *Genetics of Obesity: What have we Learned?* Curr Genomics. 2011.
- Forsythe E, Beales PL. *Bardet-Biedl Syndrome.* Eur J Hum Genet. 2013.
- Styne DM et al. *Pediatric Obesity — Assessment, Treatment, and Prevention.* JCEM 2017.
Is this your skill, or is something wrong with this listing? Request removal or report an issue. Author removals are honored within 72 hours.
No comments yet. Be the first to comment!